Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996565 · ClinicalTrials.gov registry record · NA
Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 3,071
- Enrollment target
NCT02996565: Completed NA study, sponsored by HealthPartners Institute.
NCT02996565 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 3,071 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (119% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02996565, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,071 participants
- Enrollment target
Study Summary
This pragmatic trial will compare two team-based care models for managing hypertension, Best Practice Clinic-based Care and Telehealth Care with pharmacist management, in a large care system in Minnesota. Clinics in the study are randomized to offer one of the two treatment models to participants with uncontrolled hypertension. The investigators aim to determine a) whether one model is more effective than the other for lowering patient's blood pressure and b) which model patients prefer.
Primary Outcome
Change in systolic BP, collected from medical records
Interventions
- OTHER Best Practice Clinic-Based Care
- OTHER Telehealth Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,071 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT02996565 record still lists
NCT02996565 is an interventional study that assigns participants to a tested intervention. Its 3,071 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (119% higher).
The record links to 0 conditions, and to 2 interventions - of which Best Practice Clinic-Based Care is the first listed.
NCT02996565 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02996565 about?
NCT02996565 is a clinical study titled "Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure". This pragmatic trial will compare two team-based care models for managing hypertension, Best Practice Clinic-based Care and Telehealth Care with pharmacist management, in a large care system in Minnesota. Clinics in the study are randomized to offer one of the two treatment models to participants wi...
What is the current status of trial NCT02996565?
This trial is currently completed. It is a NA study. The enrollment target is 3,071 participants. The study started on 2017-11-15. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT02996565?
The interventions under investigation include: Best Practice Clinic-Based Care (OTHER), Telehealth Care (OTHER).
Who is sponsoring clinical trial NCT02996565?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02996565's enrollment target sits among peer trials
3,071 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI